Global RNAi For Therapeutic Industry Market Research Report

Publisher Name :
Date: 17-Oct-2019
No. of pages: 113

The RNAi for Therapeutic market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the RNAi for Therapeutic industrial chain, this report mainly elaborates the definition, types, applications and major players of RNAi for Therapeutic market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2019-2024), regional industrial layout characteristics and macroeconomic policies, industrial policy has also be included. From raw materials to downstream buyers of this industry will be analyzed scientifically, the feature of product circulation and sales channel will be presented as well. In a word, this report will help you to establish a panorama of industrial development and characteristics of the RNAi for Therapeutic market.

The RNAi for Therapeutic market can be split based on product types, major applications, and important regions.

Major Players in RNAi for Therapeutic market are:

Sylentis

Celsion Corporation

Ascletis Pharmaceuticals

Calando Pharmaceuticals

Silence Therapeutics

Creative Animodel

Celgene

Roche Innovation Center Copenhagen (formerly Santaris Pharma)

GeneCopoeia

Bayer Heathcare

CombiMatrix

Alnylam Pharmaceuticals

Quark Pharmaceuticals

Ensysce Biosciences

Biogazelle

Silenseed

AstraZeneca

Gradalis Incorporated

Tekmira Pharmaceuticals.

RXi Pharmaceuticals

Arrowhead Research

Benitec Biopharma

BioSpring

Astellas Pharma

Major Regions that plays a vital role in RNAi for Therapeutic market are:

North America

Europe

China

Japan

Middle East & Africa

India

South America

Others

Most important types of RNAi for Therapeutic products covered in this report are:

siRNA

miRNA

shRNA

Most widely used downstream fields of RNAi for Therapeutic market covered in this report are:

Cancer

Cardiovascular

HBV

Others

There are 13 Chapters to thoroughly display the RNAi for Therapeutic market. This report included the analysis of market overview, market characteristics, industry chain, competition landscape, historical and future data by types, applications and regions.

Chapter 1: RNAi for Therapeutic Market Overview, Product Overview, Market Segmentation, Market Overview of Regions, Market Dynamics, Limitations, Opportunities and Industry News and Policies.

Chapter 2: RNAi for Therapeutic Industry Chain Analysis, Upstream Raw Material Suppliers, Major Players, Production Process Analysis, Cost Analysis, Market Channels and Major Downstream Buyers.

Chapter 3: Value Analysis, Production, Growth Rate and Price Analysis by Type of RNAi for Therapeutic.

Chapter 4: Downstream Characteristics, Consumption and Market Share by Application of RNAi for Therapeutic.

Chapter 5: Production Volume, Price, Gross Margin, and Revenue ($) of RNAi for Therapeutic by Regions (2014-2019).

Chapter 6: RNAi for Therapeutic Production, Consumption, Export and Import by Regions (2014-2019).

Chapter 7: RNAi for Therapeutic Market Status and SWOT Analysis by Regions.

Chapter 8: Competitive Landscape, Product Introduction, Company Profiles, Market Distribution Status by Players of RNAi for Therapeutic.

Chapter 9: RNAi for Therapeutic Market Analysis and Forecast by Type and Application (2019-2024).

Chapter 10: Market Analysis and Forecast by Regions (2019-2024).

Chapter 11: Industry Characteristics, Key Factors, New Entrants SWOT Analysis, Investment Feasibility Analysis.

Chapter 12: Market Conclusion of the Whole Report.

Chapter 13: Appendix Such as Methodology and Data Resources of This Research.

Global RNAi For Therapeutic Industry Market Research Report

Table of Contents

Global RNAi for Therapeutic Industry Market Research Report
1 RNAi for Therapeutic Introduction and Market Overview
1.1 Objectives of the Study
1.2 Definition of RNAi for Therapeutic
1.3 RNAi for Therapeutic Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global RNAi for Therapeutic Value ($) and Growth Rate from 2014-2024
1.4 Market Segmentation
1.4.1 Types of RNAi for Therapeutic
1.4.2 Applications of RNAi for Therapeutic
1.4.3 Research Regions
1.4.3.1 North America RNAi for Therapeutic Production Value ($) and Growth Rate (2014-2019)
1.4.3.2 Europe RNAi for Therapeutic Production Value ($) and Growth Rate (2014-2019)
1.4.3.3 China RNAi for Therapeutic Production Value ($) and Growth Rate (2014-2019)
1.4.3.4 Japan RNAi for Therapeutic Production Value ($) and Growth Rate (2014-2019)
1.4.3.5 Middle East & Africa RNAi for Therapeutic Production Value ($) and Growth Rate (2014-2019)
1.4.3.6 India RNAi for Therapeutic Production Value ($) and Growth Rate (2014-2019)
1.4.3.7 South America RNAi for Therapeutic Production Value ($) and Growth Rate (2014-2019)
1.5 Market Dynamics
1.5.1 Drivers
1.5.1.1 Emerging Countries of RNAi for Therapeutic
1.5.1.2 Growing Market of RNAi for Therapeutic
1.5.2 Limitations
1.5.3 Opportunities
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies

2 Industry Chain Analysis
2.1 Upstream Raw Material Suppliers of RNAi for Therapeutic Analysis
2.2 Major Players of RNAi for Therapeutic
2.2.1 Major Players Manufacturing Base and Market Share of RNAi for Therapeutic in 2018
2.2.2 Major Players Product Types in 2018
2.3 RNAi for Therapeutic Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of RNAi for Therapeutic
2.3.3 Raw Material Cost of RNAi for Therapeutic
2.3.4 Labor Cost of RNAi for Therapeutic
2.4 Market Channel Analysis of RNAi for Therapeutic
2.5 Major Downstream Buyers of RNAi for Therapeutic Analysis

3 Global RNAi for Therapeutic Market, by Type
3.1 Global RNAi for Therapeutic Value ($) and Market Share by Type (2014-2019)
3.2 Global RNAi for Therapeutic Production and Market Share by Type (2014-2019)
3.3 Global RNAi for Therapeutic Value ($) and Growth Rate by Type (2014-2019)
3.4 Global RNAi for Therapeutic Price Analysis by Type (2014-2019)

4 RNAi for Therapeutic Market, by Application
4.1 Global RNAi for Therapeutic Consumption and Market Share by Application (2014-2019)
4.2 Downstream Buyers by Application
4.3 Global RNAi for Therapeutic Consumption and Growth Rate by Application (2014-2019)

5 Global RNAi for Therapeutic Production, Value ($) by Region (2014-2019)
5.1 Global RNAi for Therapeutic Value ($) and Market Share by Region (2014-2019)
5.2 Global RNAi for Therapeutic Production and Market Share by Region (2014-2019)
5.3 Global RNAi for Therapeutic Production, Value ($), Price and Gross Margin (2014-2019)
5.4 North America RNAi for Therapeutic Production, Value ($), Price and Gross Margin (2014-2019)
5.5 Europe RNAi for Therapeutic Production, Value ($), Price and Gross Margin (2014-2019)
5.6 China RNAi for Therapeutic Production, Value ($), Price and Gross Margin (2014-2019)
5.7 Japan RNAi for Therapeutic Production, Value ($), Price and Gross Margin (2014-2019)
5.8 Middle East & Africa RNAi for Therapeutic Production, Value ($), Price and Gross Margin (2014-2019)
5.9 India RNAi for Therapeutic Production, Value ($), Price and Gross Margin (2014-2019)
5.10 South America RNAi for Therapeutic Production, Value ($), Price and Gross Margin (2014-2019)

6 Global RNAi for Therapeutic Production, Consumption, Export, Import by Regions (2014-2019)
6.1 Global RNAi for Therapeutic Consumption by Regions (2014-2019)
6.2 North America RNAi for Therapeutic Production, Consumption, Export, Import (2014-2019)
6.3 Europe RNAi for Therapeutic Production, Consumption, Export, Import (2014-2019)
6.4 China RNAi for Therapeutic Production, Consumption, Export, Import (2014-2019)
6.5 Japan RNAi for Therapeutic Production, Consumption, Export, Import (2014-2019)
6.6 Middle East & Africa RNAi for Therapeutic Production, Consumption, Export, Import (2014-2019)
6.7 India RNAi for Therapeutic Production, Consumption, Export, Import (2014-2019)
6.8 South America RNAi for Therapeutic Production, Consumption, Export, Import (2014-2019)

7 Global RNAi for Therapeutic Market Status and SWOT Analysis by Regions
7.1 North America RNAi for Therapeutic Market Status and SWOT Analysis
7.2 Europe RNAi for Therapeutic Market Status and SWOT Analysis
7.3 China RNAi for Therapeutic Market Status and SWOT Analysis
7.4 Japan RNAi for Therapeutic Market Status and SWOT Analysis
7.5 Middle East & Africa RNAi for Therapeutic Market Status and SWOT Analysis
7.6 India RNAi for Therapeutic Market Status and SWOT Analysis
7.7 South America RNAi for Therapeutic Market Status and SWOT Analysis

8 Competitive Landscape
8.1 Competitive Profile
8.2 Sylentis
8.2.1 Company Profiles
8.2.2 RNAi for Therapeutic Product Introduction
8.2.3 Sylentis Production, Value ($), Price, Gross Margin 2014-2019
8.2.4 Sylentis Market Share of RNAi for Therapeutic Segmented by Region in 2018
8.3 Celsion Corporation
8.3.1 Company Profiles
8.3.2 RNAi for Therapeutic Product Introduction
8.3.3 Celsion Corporation Production, Value ($), Price, Gross Margin 2014-2019
8.3.4 Celsion Corporation Market Share of RNAi for Therapeutic Segmented by Region in 2018
8.4 Ascletis Pharmaceuticals
8.4.1 Company Profiles
8.4.2 RNAi for Therapeutic Product Introduction
8.4.3 Ascletis Pharmaceuticals Production, Value ($), Price, Gross Margin 2014-2019
8.4.4 Ascletis Pharmaceuticals Market Share of RNAi for Therapeutic Segmented by Region in 2018
8.5 Calando Pharmaceuticals
8.5.1 Company Profiles
8.5.2 RNAi for Therapeutic Product Introduction
8.5.3 Calando Pharmaceuticals Production, Value ($), Price, Gross Margin 2014-2019
8.5.4 Calando Pharmaceuticals Market Share of RNAi for Therapeutic Segmented by Region in 2018
8.6 Silence Therapeutics
8.6.1 Company Profiles
8.6.2 RNAi for Therapeutic Product Introduction
8.6.3 Silence Therapeutics Production, Value ($), Price, Gross Margin 2014-2019
8.6.4 Silence Therapeutics Market Share of RNAi for Therapeutic Segmented by Region in 2018
8.7 Creative Animodel
8.7.1 Company Profiles
8.7.2 RNAi for Therapeutic Product Introduction
8.7.3 Creative Animodel Production, Value ($), Price, Gross Margin 2014-2019
8.7.4 Creative Animodel Market Share of RNAi for Therapeutic Segmented by Region in 2018
8.8 Celgene
8.8.1 Company Profiles
8.8.2 RNAi for Therapeutic Product Introduction
8.8.3 Celgene Production, Value ($), Price, Gross Margin 2014-2019
8.8.4 Celgene Market Share of RNAi for Therapeutic Segmented by Region in 2018
8.9 Roche Innovation Center Copenhagen (formerly Santaris Pharma)
8.9.1 Company Profiles
8.9.2 RNAi for Therapeutic Product Introduction
8.9.3 Roche Innovation Center Copenhagen (formerly Santaris Pharma) Production, Value ($), Price, Gross Margin 2014-2019
8.9.4 Roche Innovation Center Copenhagen (formerly Santaris Pharma) Market Share of RNAi for Therapeutic Segmented by Region in 2018
8.10 GeneCopoeia
8.10.1 Company Profiles
8.10.2 RNAi for Therapeutic Product Introduction
8.10.3 GeneCopoeia Production, Value ($), Price, Gross Margin 2014-2019
8.10.4 GeneCopoeia Market Share of RNAi for Therapeutic Segmented by Region in 2018
8.11 Bayer Heathcare
8.11.1 Company Profiles
8.11.2 RNAi for Therapeutic Product Introduction
8.11.3 Bayer Heathcare Production, Value ($), Price, Gross Margin 2014-2019
8.11.4 Bayer Heathcare Market Share of RNAi for Therapeutic Segmented by Region in 2018
8.12 CombiMatrix
8.12.1 Company Profiles
8.12.2 RNAi for Therapeutic Product Introduction
8.12.3 CombiMatrix Production, Value ($), Price, Gross Margin 2014-2019
8.12.4 CombiMatrix Market Share of RNAi for Therapeutic Segmented by Region in 2018
8.13 Alnylam Pharmaceuticals
8.13.1 Company Profiles
8.13.2 RNAi for Therapeutic Product Introduction
8.13.3 Alnylam Pharmaceuticals Production, Value ($), Price, Gross Margin 2014-2019
8.13.4 Alnylam Pharmaceuticals Market Share of RNAi for Therapeutic Segmented by Region in 2018
8.14 Quark Pharmaceuticals
8.14.1 Company Profiles
8.14.2 RNAi for Therapeutic Product Introduction
8.14.3 Quark Pharmaceuticals Production, Value ($), Price, Gross Margin 2014-2019
8.14.4 Quark Pharmaceuticals Market Share of RNAi for Therapeutic Segmented by Region in 2018
8.15 Ensysce Biosciences
8.15.1 Company Profiles
8.15.2 RNAi for Therapeutic Product Introduction
8.15.3 Ensysce Biosciences Production, Value ($), Price, Gross Margin 2014-2019
8.15.4 Ensysce Biosciences Market Share of RNAi for Therapeutic Segmented by Region in 2018
8.16 Biogazelle
8.16.1 Company Profiles
8.16.2 RNAi for Therapeutic Product Introduction
8.16.3 Biogazelle Production, Value ($), Price, Gross Margin 2014-2019
8.16.4 Biogazelle Market Share of RNAi for Therapeutic Segmented by Region in 2018
8.17 Silenseed
8.18 AstraZeneca
8.19 Gradalis Incorporated
8.20 Tekmira Pharmaceuticals.
8.21 RXi Pharmaceuticals
8.22 Arrowhead Research
8.23 Benitec Biopharma
8.24 BioSpring
8.25 Astellas Pharma

9 Global RNAi for Therapeutic Market Analysis and Forecast by Type and Application
9.1 Global RNAi for Therapeutic Market Value ($) & Volume Forecast, by Type (2019-2024)
9.1.1 siRNA Market Value ($) and Volume Forecast (2019-2024)
9.1.2 miRNA Market Value ($) and Volume Forecast (2019-2024)
9.1.3 shRNA Market Value ($) and Volume Forecast (2019-2024)
9.2 Global RNAi for Therapeutic Market Value ($) & Volume Forecast, by Application (2019-2024)
9.2.1 Cancer Market Value ($) and Volume Forecast (2019-2024)
9.2.2 Cardiovascular Market Value ($) and Volume Forecast (2019-2024)
9.2.3 HBV Market Value ($) and Volume Forecast (2019-2024)
9.2.4 Others Market Value ($) and Volume Forecast (2019-2024)

10 RNAi for Therapeutic Market Analysis and Forecast by Region
10.1 North America Market Value ($) and Consumption Forecast (2019-2024)
10.2 Europe Market Value ($) and Consumption Forecast (2019-2024)
10.3 China Market Value ($) and Consumption Forecast (2019-2024)
10.4 Japan Market Value ($) and Consumption Forecast (2019-2024)
10.5 Middle East & Africa Market Value ($) and Consumption Forecast (2019-2024)
10.6 India Market Value ($) and Consumption Forecast (2019-2024)
10.7 South America Market Value ($) and Consumption Forecast (2019-2024)

11 New Project Feasibility Analysis
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment

12 Research Finding and Conclusion

13 Appendix
13.1 Discussion Guide
13.2 Knowledge Store: Maia Subscription Portal
13.3 Research Data Source
13.4 Research Assumptions and Acronyms Used

List of Tables and Figures

Figure Product Picture of RNAi for Therapeutic
Table Product Specification of RNAi for Therapeutic
Figure Market Concentration Ratio and Market Maturity Analysis of RNAi for Therapeutic
Figure Global RNAi for Therapeutic Value ($) and Growth Rate from 2014-2024
Table Different Types of RNAi for Therapeutic
Figure Global RNAi for Therapeutic Value ($) Segment by Type from 2014-2019
Figure siRNA Picture
Figure miRNA Picture
Figure shRNA Picture
Table Different Applications of RNAi for Therapeutic
Figure Global RNAi for Therapeutic Value ($) Segment by Applications from 2014-2019
Figure Cancer Picture
Figure Cardiovascular Picture
Figure HBV Picture
Figure Others Picture
Table Research Regions of RNAi for Therapeutic
Figure North America RNAi for Therapeutic Production Value ($) and Growth Rate (2014-2019)
Figure Europe RNAi for Therapeutic Production Value ($) and Growth Rate (2014-2019)
Table China RNAi for Therapeutic Production Value ($) and Growth Rate (2014-2019)
Table Japan RNAi for Therapeutic Production Value ($) and Growth Rate (2014-2019)
Table Middle East & Africa RNAi for Therapeutic Production Value ($) and Growth Rate (2014-2019)
Table India RNAi for Therapeutic Production Value ($) and Growth Rate (2014-2019)
Table South America RNAi for Therapeutic Production Value ($) and Growth Rate (2014-2019)
Table Emerging Countries of RNAi for Therapeutic
Table Growing Market of RNAi for Therapeutic
Figure Industry Chain Analysis of RNAi for Therapeutic
Table Upstream Raw Material Suppliers of RNAi for Therapeutic with Contact Information
Table Major Players Manufacturing Base and Market Share ($) of RNAi for Therapeutic in 2018
Table Major Players RNAi for Therapeutic Product Types in 2018
Figure Production Process of RNAi for Therapeutic
Figure Manufacturing Cost Structure of RNAi for Therapeutic
Figure Channel Status of RNAi for Therapeutic
Table Major Distributors of RNAi for Therapeutic with Contact Information
Table Major Downstream Buyers of RNAi for Therapeutic with Contact Information
Table Global RNAi for Therapeutic Value ($) by Type (2014-2019)
Table Global RNAi for Therapeutic Value ($) Share by Type (2014-2019)
Figure Global RNAi for Therapeutic Value ($) Share by Type (2014-2019)
Table Global RNAi for Therapeutic Production by Type (2014-2019)
Table Global RNAi for Therapeutic Production Share by Type (2014-2019)
Figure Global RNAi for Therapeutic Production Share by Type (2014-2019)
Figure Global RNAi for Therapeutic Value ($) and Growth Rate of siRNA
Figure Global RNAi for Therapeutic Value ($) and Growth Rate of miRNA
Figure Global RNAi for Therapeutic Value ($) and Growth Rate of shRNA
Figure Global RNAi for Therapeutic Price by Type (2014-2019)
Table Global RNAi for Therapeutic Consumption by Application (2014-2019)
Table Global RNAi for Therapeutic Consumption Market Share by Application (2014-2019)
Figure Global RNAi for Therapeutic Consumption Market Share by Application (2014-2019)
Table Downstream Buyers Introduction by Application
Figure Global RNAi for Therapeutic Consumption and Growth Rate of Cancer (2014-2019)
Figure Global RNAi for Therapeutic Consumption and Growth Rate of Cardiovascular (2014-2019)
Figure Global RNAi for Therapeutic Consumption and Growth Rate of HBV (2014-2019)
Figure Global RNAi for Therapeutic Consumption and Growth Rate of Others (2014-2019)
Table Global RNAi for Therapeutic Value ($) by Region (2014-2019)
Table Global RNAi for Therapeutic Value ($) Market Share by Region (2014-2019)
Figure Global RNAi for Therapeutic Value ($) Market Share by Region (2014-2019)
Table Global RNAi for Therapeutic Production by Region (2014-2019)
Table Global RNAi for Therapeutic Production Market Share by Region (2014-2019)
Figure Global RNAi for Therapeutic Production Market Share by Region (2014-2019)
Table Global RNAi for Therapeutic Production, Value ($), Price and Gross Margin (2014-2019)
Table North America RNAi for Therapeutic Production, Value ($), Price and Gross Margin (2014-2019)
Table Europe RNAi for Therapeutic Production, Value ($), Price and Gross Margin (2014-2019)
Table China RNAi for Therapeutic Production, Value ($), Price and Gross Margin (2014-2019)
Table Japan RNAi for Therapeutic Production, Value ($), Price and Gross Margin (2014-2019)
Table Middle East & Africa RNAi for Therapeutic Production, Value ($), Price and Gross Margin (2014-2019)
Table India RNAi for Therapeutic Production, Value ($), Price and Gross Margin (2014-2019)
Table South America RNAi for Therapeutic Production, Value ($), Price and Gross Margin (2014-2019)
Table Global RNAi for Therapeutic Consumption by Regions (2014-2019)
Figure Global RNAi for Therapeutic Consumption Share by Regions (2014-2019)
Table North America RNAi for Therapeutic Production, Consumption, Export, Import (2014-2019)
Table Europe RNAi for Therapeutic Production, Consumption, Export, Import (2014-2019)
Table China RNAi for Therapeutic Production, Consumption, Export, Import (2014-2019)
Table Japan RNAi for Therapeutic Production, Consumption, Export, Import (2014-2019)
Table Middle East & Africa RNAi for Therapeutic Production, Consumption, Export, Import (2014-2019)
Table India RNAi for Therapeutic Production, Consumption, Export, Import (2014-2019)
Table South America RNAi for Therapeutic Production, Consumption, Export, Import (2014-2019)
Figure North America RNAi for Therapeutic Production and Growth Rate Analysis
Figure North America RNAi for Therapeutic Consumption and Growth Rate Analysis
Figure North America RNAi for Therapeutic SWOT Analysis
Figure Europe RNAi for Therapeutic Production and Growth Rate Analysis
Figure Europe RNAi for Therapeutic Consumption and Growth Rate Analysis
Figure Europe RNAi for Therapeutic SWOT Analysis
Figure China RNAi for Therapeutic Production and Growth Rate Analysis
Figure China RNAi for Therapeutic Consumption and Growth Rate Analysis
Figure China RNAi for Therapeutic SWOT Analysis
Figure Japan RNAi for Therapeutic Production and Growth Rate Analysis
Figure Japan RNAi for Therapeutic Consumption and Growth Rate Analysis
Figure Japan RNAi for Therapeutic SWOT Analysis
Figure Middle East & Africa RNAi for Therapeutic Production and Growth Rate Analysis
Figure Middle East & Africa RNAi for Therapeutic Consumption and Growth Rate Analysis
Figure Middle East & Africa RNAi for Therapeutic SWOT Analysis
Figure India RNAi for Therapeutic Production and Growth Rate Analysis
Figure India RNAi for Therapeutic Consumption and Growth Rate Analysis
Figure India RNAi for Therapeutic SWOT Analysis
Figure South America RNAi for Therapeutic Production and Growth Rate Analysis
Figure South America RNAi for Therapeutic Consumption and Growth Rate Analysis
Figure South America RNAi for Therapeutic SWOT Analysis
Figure Top 3 Market Share of RNAi for Therapeutic Companies
Figure Top 6 Market Share of RNAi for Therapeutic Companies
Table Mergers, Acquisitions and Expansion Analysis
Table Company Profiles
Table Product Introduction
Table Sylentis Production, Value ($), Price, Gross Margin 2014-2019
Figure Sylentis Production and Growth Rate
Figure Sylentis Value ($) Market Share 2014-2019
Figure Sylentis Market Share of RNAi for Therapeutic Segmented by Region in 2018
Table Company Profiles
Table Product Introduction
Table Celsion Corporation Production, Value ($), Price, Gross Margin 2014-2019
Figure Celsion Corporation Production and Growth Rate
Figure Celsion Corporation Value ($) Market Share 2014-2019
Figure Celsion Corporation Market Share of RNAi for Therapeutic Segmented by Region in 2018
Table Company Profiles
Table Product Introduction
Table Ascletis Pharmaceuticals Production, Value ($), Price, Gross Margin 2014-2019
Figure Ascletis Pharmaceuticals Production and Growth Rate
Figure Ascletis Pharmaceuticals Value ($) Market Share 2014-2019
Figure Ascletis Pharmaceuticals Market Share of RNAi for Therapeutic Segmented by Region in 2018
Table Company Profiles
Table Product Introduction
Table Calando Pharmaceuticals Production, Value ($), Price, Gross Margin 2014-2019
Figure Calando Pharmaceuticals Production and Growth Rate
Figure Calando Pharmaceuticals Value ($) Market Share 2014-2019
Figure Calando Pharmaceuticals Market Share of RNAi for Therapeutic Segmented by Region in 2018
Table Company Profiles
Table Product Introduction
Table Silence Therapeutics Production, Value ($), Price, Gross Margin 2014-2019
Figure Silence Therapeutics Production and Growth Rate
Figure Silence Therapeutics Value ($) Market Share 2014-2019
Figure Silence Therapeutics Market Share of RNAi for Therapeutic Segmented by Region in 2018
Table Company Profiles
Table Product Introduction
Table Creative Animodel Production, Value ($), Price, Gross Margin 2014-2019
Figure Creative Animodel Production and Growth Rate
Figure Creative Animodel Value ($) Market Share 2014-2019
Figure Creative Animodel Market Share of RNAi for Therapeutic Segmented by Region in 2018
Table Company Profiles
Table Product Introduction
Table Celgene Production, Value ($), Price, Gross Margin 2014-2019
Figure Celgene Production and Growth Rate
Figure Celgene Value ($) Market Share 2014-2019
Figure Celgene Market Share of RNAi for Therapeutic Segmented by Region in 2018
Table Company Profiles
Table Product Introduction
Table Roche Innovation Center Copenhagen (formerly Santaris Pharma) Production, Value ($), Price, Gross Margin 2014-2019
Figure Roche Innovation Center Copenhagen (formerly Santaris Pharma) Production and Growth Rate
Figure Roche Innovation Center Copenhagen (formerly Santaris Pharma) Value ($) Market Share 2014-2019
Figure Roche Innovation Center Copenhagen (formerly Santaris Pharma) Market Share of RNAi for Therapeutic Segmented by Region in 2018
Table Company Profiles
Table Product Introduction
Table GeneCopoeia Production, Value ($), Price, Gross Margin 2014-2019
Figure GeneCopoeia Production and Growth Rate
Figure GeneCopoeia Value ($) Market Share 2014-2019
Figure GeneCopoeia Market Share of RNAi for Therapeutic Segmented by Region in 2018
Table Company Profiles
Table Product Introduction
Table Bayer Heathcare Production, Value ($), Price, Gross Margin 2014-2019
Figure Bayer Heathcare Production and Growth Rate
Figure Bayer Heathcare Value ($) Market Share 2014-2019
Figure Bayer Heathcare Market Share of RNAi for Therapeutic Segmented by Region in 2018
Table Company Profiles
Table Product Introduction
Table CombiMatrix Production, Value ($), Price, Gross Margin 2014-2019
Figure CombiMatrix Production and Growth Rate
Figure CombiMatrix Value ($) Market Share 2014-2019
Figure CombiMatrix Market Share of RNAi for Therapeutic Segmented by Region in 2018
Table Company Profiles
Table Product Introduction
Table Alnylam Pharmaceuticals Production, Value ($), Price, Gross Margin 2014-2019
Figure Alnylam Pharmaceuticals Production and Growth Rate
Figure Alnylam Pharmaceuticals Value ($) Market Share 2014-2019
Figure Alnylam Pharmaceuticals Market Share of RNAi for Therapeutic Segmented by Region in 2018
Table Company Profiles
Table Product Introduction
Table Quark Pharmaceuticals Production, Value ($), Price, Gross Margin 2014-2019
Figure Quark Pharmaceuticals Production and Growth Rate
Figure Quark Pharmaceuticals Value ($) Market Share 2014-2019
Figure Quark Pharmaceuticals Market Share of RNAi for Therapeutic Segmented by Region in 2018
Table Company Profiles
Table Product Introduction
Table Ensysce Biosciences Production, Value ($), Price, Gross Margin 2014-2019
Figure Ensysce Biosciences Production and Growth Rate
Figure Ensysce Biosciences Value ($) Market Share 2014-2019
Figure Ensysce Biosciences Market Share of RNAi for Therapeutic Segmented by Region in 2018
Table Company Profiles
Table Product Introduction
Table Biogazelle Production, Value ($), Price, Gross Margin 2014-2019
Figure Biogazelle Production and Growth Rate
Figure Biogazelle Value ($) Market Share 2014-2019
Figure Biogazelle Market Share of RNAi for Therapeutic Segmented by Region in 2018
Table Company Profiles
Table Product Introduction
Table Silenseed Production, Value ($), Price, Gross Margin 2014-2019
Figure Silenseed Production and Growth Rate
Figure Silenseed Value ($) Market Share 2014-2019
Figure Silenseed Market Share of RNAi for Therapeutic Segmented by Region in 2018
Table Company Profiles
Table Product Introduction
Table AstraZeneca Production, Value ($), Price, Gross Margin 2014-2019
Figure AstraZeneca Production and Growth Rate
Figure AstraZeneca Value ($) Market Share 2014-2019
Figure AstraZeneca Market Share of RNAi for Therapeutic Segmented by Region in 2018
Table Company Profiles
Table Product Introduction
Table Gradalis Incorporated Production, Value ($), Price, Gross Margin 2014-2019
Figure Gradalis Incorporated Production and Growth Rate
Figure Gradalis Incorporated Value ($) Market Share 2014-2019
Figure Gradalis Incorporated Market Share of RNAi for Therapeutic Segmented by Region in 2018
Table Company Profiles
Table Product Introduction
Table Tekmira Pharmaceuticals. Production, Value ($), Price, Gross Margin 2014-2019
Figure Tekmira Pharmaceuticals. Production and Growth Rate
Figure Tekmira Pharmaceuticals. Value ($) Market Share 2014-2019
Figure Tekmira Pharmaceuticals. Market Share of RNAi for Therapeutic Segmented by Region in 2018
Table Company Profiles
Table Product Introduction
Table RXi Pharmaceuticals Production, Value ($), Price, Gross Margin 2014-2019
Figure RXi Pharmaceuticals Production and Growth Rate
Figure RXi Pharmaceuticals Value ($) Market Share 2014-2019
Figure RXi Pharmaceuticals Market Share of RNAi for Therapeutic Segmented by Region in 2018
Table Company Profiles
Table Product Introduction
Table Arrowhead Research Production, Value ($), Price, Gross Margin 2014-2019
Figure Arrowhead Research Production and Growth Rate
Figure Arrowhead Research Value ($) Market Share 2014-2019
Figure Arrowhead Research Market Share of RNAi for Therapeutic Segmented by Region in 2018
Table Company Profiles
Table Product Introduction
Table Benitec Biopharma Production, Value ($), Price, Gross Margin 2014-2019
Figure Benitec Biopharma Production and Growth Rate
Figure Benitec Biopharma Value ($) Market Share 2014-2019
Figure Benitec Biopharma Market Share of RNAi for Therapeutic Segmented by Region in 2018
Table Company Profiles
Table Product Introduction
Table BioSpring Production, Value ($), Price, Gross Margin 2014-2019
Figure BioSpring Production and Growth Rate
Figure BioSpring Value ($) Market Share 2014-2019
Figure BioSpring Market Share of RNAi for Therapeutic Segmented by Region in 2018
Table Company Profiles
Table Product Introduction
Table Astellas Pharma Production, Value ($), Price, Gross Margin 2014-2019
Figure Astellas Pharma Production and Growth Rate
Figure Astellas Pharma Value ($) Market Share 2014-2019
Figure Astellas Pharma Market Share of RNAi for Therapeutic Segmented by Region in 2018
Table Global RNAi for Therapeutic Market Value ($) Forecast, by Type
Table Global RNAi for Therapeutic Market Volume Forecast, by Type
Figure Global RNAi for Therapeutic Market Value ($) and Growth Rate Forecast of siRNA (2019-2024)
Figure Global RNAi for Therapeutic Market Volume and Growth Rate Forecast of siRNA (2019-2024)
Figure Global RNAi for Therapeutic Market Value ($) and Growth Rate Forecast of miRNA (2019-2024)
Figure Global RNAi for Therapeutic Market Volume and Growth Rate Forecast of miRNA (2019-2024)
Figure Global RNAi for Therapeutic Market Value ($) and Growth Rate Forecast of shRNA (2019-2024)
Figure Global RNAi for Therapeutic Market Volume and Growth Rate Forecast of shRNA (2019-2024)
Table Global Market Value ($) Forecast by Application (2019-2024)
Table Global Market Volume Forecast by Application (2019-2024)
Figure Global RNAi for Therapeutic Consumption and Growth Rate of Cancer (2014-2019)
Figure Global RNAi for Therapeutic Consumption and Growth Rate of Cardiovascular (2014-2019)
Figure Global RNAi for Therapeutic Consumption and Growth Rate of HBV (2014-2019)
Figure Global RNAi for Therapeutic Consumption and Growth Rate of Others (2014-2019)
Figure Market Value ($) and Growth Rate Forecast of Others (2019-2024)
Figure Market Volume and Growth Rate Forecast of Others (2019-2024)
Figure North America Market Value ($) and Growth Rate Forecast (2019-2024)
Table North America Consumption and Growth Rate Forecast (2019-2024)
Figure Europe Market Value ($) and Growth Rate Forecast (2019-2024)
Table Europe Consumption and Growth Rate Forecast (2019-2024)
Figure China Market Value ($) and Growth Rate Forecast (2019-2024)
Table China Consumption and Growth Rate Forecast (2019-2024)
Figure Japan Market Value ($) and Growth Rate Forecast (2019-2024)
Table Japan Consumption and Growth Rate Forecast (2019-2024)
Figure Middle East & Africa Market Value ($) and Growth Rate Forecast (2019-2024)
Table Middle East & Africa Consumption and Growth Rate Forecast (2019-2024)
Figure India Market Value ($) and Growth Rate Forecast (2019-2024)
Table India Consumption and Growth Rate Forecast (2019-2024)
Figure South America Market Value ($) and Growth Rate Forecast (2019-2024)
Table South America Consumption and Growth Rate Forecast (2019-2024)
Figure Industry Resource/Technology/Labor Importance Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
  • Global Targeted RNA Sequencing Market Research Report 2020
    Published: 02-Jan-2020        Price: US 2900 Onwards        Pages: 93
    Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types. Targeted RNA-sequ......
  • Global RNAi for Therapeutic Market Size, Status and Forecast 2020-2026
    Published: 01-Jan-2020        Price: US 3900 Onwards        Pages: 90
    RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense tec......
  • Global Targeted RNA Sequencing Market Professional Survey 2019 by Manufacturers, Regions, Types and Applications, Forecast to 2024
    Published: 30-Dec-2019        Price: US 2600 Onwards        Pages: 183
    In this report, we analyze the Targeted RNA Sequencing industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2014 to 2019. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2014 to 2019. We also m......
  • Global RNA In Situ Hybridization Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application
    Published: 25-Dec-2019        Price: US 3350 Onwards        Pages: 119
    Summary In 2018, the global RNA In Situ Hybridization market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% between 2019 and 2025. This report studies the RNA In Situ Hybridization market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and ......
  • 2017-2025 World RNAi for Therapeutic Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 24-Dec-2019        Price: US 2800 Onwards        Pages: 105
    Summary RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and be......
  • Global RNAi for Therapeutic Market Research (2015-2019) and Future Forecast (2020-2025)
    Published: 20-Nov-2019        Price: US 3300 Onwards        Pages: 131
    Summary RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and be......
  • Global Targeted RNA Sequencing Market Professional Survey 2019 by Manufacturers, Regions, Countries, Types and Applications, Forecast to 2024
    Published: 18-Nov-2019        Price: US 2900 Onwards        Pages: 184
    The Targeted RNA Sequencing market was valued at XX Million US$ in 2018 and is projected to reach XX Million US$ by 2024, at a CAGR of XX% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2024 as the forecast period to estimate the market size for Targeted RNA Sequencing. Global Targeted RNA Sequencing industry market professional research 2014-2024, is a report which provides the details about industry overview, industry chain, mark......
  • Global RNAi for Therapeutic Market Study 2016-2026, by Segment (siRNA, miRNA,) , by Market (Cancer, Cardiovascular,) , by Company (Alnylam Pharmaceuticals, Arrowhead,)
    Published: 17-Nov-2019        Price: US 1800 Onwards        Pages: 57
    Summary RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and be......
  • Global RNAi for Therapeutic Market Growth (Status and Outlook) 2019-2024
    Published: 01-Nov-2019        Price: US 3660 Onwards        Pages: 132
    According to this study, over the next five years the RNAi for Therapeutic market will register a 24.0% CAGR in terms of revenue, the global market size will reach US$ 2802.7 million by 2024, from US$ 1186.9 million in 2019. In particular, this report presents the global revenue market share of key companies in RNAi for Therapeutic business, shared in Chapter 3. This report presents a comprehensive overview, market shares and growth opportunities of RNAi for Therapeutic market by ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs